TABLE 4
FROM:
Increased Expression of FGF-8 Isoforms and FGF Receptors in Human Premalignant Prostatic Intraepithelial Neoplasia Lesions and Prostate Cancer
Eeva M Valve, Marja T Nevalainen, Martti J Nurmi, Matti K Laato, Paula M Martikainen and Pirkko L Härkönen
BACK TO ARTICLETable 4. Summary of the Results of Immunohistochemical Stainings for FGF-8 and FGFR1 and FGFR2 in Prostate Cancer
| Prostate cancer | Grade (WHO) | Gleason grade | FGF-8 | FGFR1 | FGFR2 |
|---|---|---|---|---|---|
| P9 | I | 3 + 2 | 0/+ | +++ | N/A |
| PIN | ++/+++ | +++ | N/A | ||
| P31 | I | 2 + 3 | 0/+ | ++ | N/A |
| PIN | ++ | ++ | N/A | ||
| P69 | I | 2 + 4 | 0/++ | N/A | N/A |
| PIN | ++ | N/A | N/A | ||
| P54 | II | 3 + 5 | +/++ | ++ | N/A |
| P65 | II | 3 + 4 | + | N/A | N/A |
| P68 | II | 3 + 3 | +++ | N/A | N/A |
| P70 | II | 4 + 3 | ++/+++ | ++ | + |
| P88 | II | 3 + 3 | + | ++ | + |
| PIN | +/++ | ++ | + | ||
| P90 | II | 3 + 3 | 0/+++ | ++/+++ | +/++ |
| PIN | 0/++ | ++/+++ | +/++ | ||
| Normal | 0/+ | 0 | 0 | ||
| P91 | II | 3 + 4 | ++ | 0/+++ | 0/++ |
| PIN | +/++ | 0/+++ | 0/++ | ||
| Normal | 0/+ | 0 | 0 | ||
| P92 | II | 3 + 4 | 0/+ | +/+++ | 0/++ |
| PIN | +/++ | + | 0/++ | ||
| Normal | 0/+ | 0 | 0 | ||
| P8 | III | 4 + 4 | + | ++ | ++ |
| P46 | III | 3 + 5 | ++ | ++/+++ | ++ |
N/A, not analyzed.
Intensity of immunoreactivity: 0, none; +, weak; ++, moderate; +++, strong; 0/+, 0/++, 0/+++, +/++, +/+++, ++/+++: heterogenous distribution of immunoreactivity.
